- +124.4% price growth over the last year
- Healthy interest coverage ratio of 37.5x
- Strong return on equity of 215.3%
Interpace Diagnostics Group stock upgraded from Sell Candidate to Hold/Accumulate after Wednesday trading session
(Updated on Jun 03, 2026)
The Interpace Diagnostics Group stock price fell by -0.568% on the last day (Wednesday, 3rd Jun 2026) from $1.76 to $1.75. During the last trading day the stock fluctuated 2.94% from a day low at $1.70 to a day high of $1.75. The price has been going up and down for this period, and there has been a -2.78% loss for the last 2 weeks. Volume has increased on the last day by 239 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 thousand shares were bought and sold for approximately $2.71 thousand.
The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.70 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.42% during the next 3 months and, with a 90% probability hold a price between $1.78 and $2.46 at the end of this 3-month period.
IDXG Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, May 29, 2026, and so far it has risen 2.94%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Interpace Diagnostics Group stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.76 and $1.92. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Interpace Diagnostics Group gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Interpace Diagnostics Group stock
Interpace Diagnostics Group finds support from accumulated volume at $1.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0500 between high and low, or 2.94%. For the last week, the stock has had daily average volatility of 1.92%.
Our recommended stop-loss: $1.67 (-4.38%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 3 days ago.)
Trading Expectations (IDXG) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Interpace Diagnostics Group to open at $1.73, and during the day (based on 14 day Average True Range), to move between $1.71 and $1.79, which gives a possible trading interval of +/-$0.0790 (+/-4.62%) up or down from last closing price. If Interpace Diagnostics Group takes out the full calculated possible swing range there will be an estimated 4.62% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $1.73 (1.14%) than the resistance at $1.80 (2.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Interpace Diagnostics Group stock A Buy?
Interpace Diagnostics Group holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
-0.615
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $1.73 ( 0.95%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
IDXG Performance
Trading levels for IDXG
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.78 | 1.90% |
| R2 | 1.76 | 0.81% |
| R1 | 1.75 | 0.139% |
| Price | 1.75 | |
| S1 | 1.71 | -2.04% |
| S2 | 1.70 | -2.72% |
| S3 | 1.68 | -3.81% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.13 | 21.71% |
| R2 | 1.89 | 8.00% |
| R1 | 1.80 | 2.86% |
| Price | 1.75 | |
| S1 | 1.73 | -1.14% |
| S2 | 1.72 | -1.71% |
| S3 | 1.66 | -5.14% |
FAQ
Click here for our free guide on how to buy Interpace Diagnostics Group Stock.
Buy IDXG